Renal mucormycosis in post-COVID patients in Australia

Renal mucormycosis is a rare entity that has been described with significant associated morbidity and mortality. It is an opportunistic infection affecting immunocompromised patients. With the pandemic of COVID-19, we report the first case of renal mucormycosis in Australia secondary to COVID-19 and...

Full description

Bibliographic Details
Main Authors: Matthew Chau, Nicole Swarbrick, Jennifer Kong
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Urology Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2214442023000396
_version_ 1797903399499333632
author Matthew Chau
Nicole Swarbrick
Jennifer Kong
author_facet Matthew Chau
Nicole Swarbrick
Jennifer Kong
author_sort Matthew Chau
collection DOAJ
description Renal mucormycosis is a rare entity that has been described with significant associated morbidity and mortality. It is an opportunistic infection affecting immunocompromised patients. With the pandemic of COVID-19, we report the first case of renal mucormycosis in Australia secondary to COVID-19 and its management.
first_indexed 2024-04-10T09:32:17Z
format Article
id doaj.art-bc06b1c2c0d744bab03008ad326a5d4e
institution Directory Open Access Journal
issn 2214-4420
language English
last_indexed 2024-04-10T09:32:17Z
publishDate 2023-03-01
publisher Elsevier
record_format Article
series Urology Case Reports
spelling doaj.art-bc06b1c2c0d744bab03008ad326a5d4e2023-02-19T04:25:44ZengElsevierUrology Case Reports2214-44202023-03-0147102353Renal mucormycosis in post-COVID patients in AustraliaMatthew Chau0Nicole Swarbrick1Jennifer Kong2Department of Urology, Sir Charles Gairdner Hospital, Perth, WA, Australia; Corresponding author.Department of Anatomical Pathology, PathWest Laboratory Medicine, Perth, WA, Australia; Division of Pathology and Laboratory Medicine, Medical School, University of Western Australia, Perth, WA, AustraliaDepartment of Urology, Sir Charles Gairdner Hospital, Perth, WA, AustraliaRenal mucormycosis is a rare entity that has been described with significant associated morbidity and mortality. It is an opportunistic infection affecting immunocompromised patients. With the pandemic of COVID-19, we report the first case of renal mucormycosis in Australia secondary to COVID-19 and its management.http://www.sciencedirect.com/science/article/pii/S2214442023000396
spellingShingle Matthew Chau
Nicole Swarbrick
Jennifer Kong
Renal mucormycosis in post-COVID patients in Australia
Urology Case Reports
title Renal mucormycosis in post-COVID patients in Australia
title_full Renal mucormycosis in post-COVID patients in Australia
title_fullStr Renal mucormycosis in post-COVID patients in Australia
title_full_unstemmed Renal mucormycosis in post-COVID patients in Australia
title_short Renal mucormycosis in post-COVID patients in Australia
title_sort renal mucormycosis in post covid patients in australia
url http://www.sciencedirect.com/science/article/pii/S2214442023000396
work_keys_str_mv AT matthewchau renalmucormycosisinpostcovidpatientsinaustralia
AT nicoleswarbrick renalmucormycosisinpostcovidpatientsinaustralia
AT jenniferkong renalmucormycosisinpostcovidpatientsinaustralia